Effects of neuropeptide Y, calcitonin gene-related peptide, substance P, and capsaicin on cerebral arteries in man and animals.
暂无分享,去创建一个
[1] A. Franco‐Cereceda,et al. Calcitonin gene-related peptide but not substance P mimics capsaicin-induced coronary vasodilation in the pig. , 1987, European journal of pharmacology.
[2] J. Pernow,et al. Actions of calcium antagonists on pre- and postjunctional effects of neuropeptide Y on human peripheral blood vessels in vitro. , 1987, European journal of pharmacology.
[3] G. Rinaldi,et al. Dissociation between calcium influx blockage and smooth muscle relaxation by nifedipine in spontaneously hypertensive rats. , 1987, Circulation research.
[4] P. Emson,et al. Nerve Fibers Containing Neuropeptide Y in the Cerebrovascular Bed: Immunocytochemistry, Radioimmunoassay, and Vasomotor Effects , 1987, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[5] A. Sollevi,et al. Elevations of neuropeptide Y‐like immunoreactivity and catecholamines in plasma on increased intracranial pressure in the pig , 1987, Acta anaesthesiologica Scandinavica.
[6] T. Godfraind. Calcium entry blockade and excitation contraction coupling in the cardiovascular system (with an attempt of pharmacological classification). , 2009, Acta pharmacologica et toxicologica.
[7] P. Hjemdahl,et al. Plasma neuropeptide Y-like immunoreactivity and catecholamines during various degrees of sympathetic activation in man. , 2008, Clinical physiology.
[8] J. Pernow,et al. Neuropeptide Y constricts human skeletal muscle arteries via a nifedipine-sensitive mechanism independent of extracellular calcium? , 1986, Acta physiologica Scandinavica.
[9] J. Mcculloch,et al. Calcitonin gene-related peptide: functional role in cerebrovascular regulation. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[10] S. St.-Pierre,et al. The vasoconstrictor effect of neuropeptide Y and related peptides in the guinea pig isolated heart , 1986, Peptides.
[11] A. Saria,et al. Simultaneous release of several tachykinins and calcitonin gene-related peptide from rat spinal cord slices , 1986, Neuroscience Letters.
[12] A. Sollevi,et al. Frequency- and reserpine-dependent chemical coding of sympathetic transmission: Differential release of noradrenaline and neuropeptide Y from pig spleen , 1986, Neuroscience Letters.
[13] G. Fried,et al. NPY--a mediator of reserpine-resistant, non-adrenergic vasoconstriction in cat spleen after preganglionic denervation? , 1986, Acta physiologica Scandinavica.
[14] L. Edvinsson. Functional role of perivascular peptides in the control of cerebral circulation , 1985, Trends in Neurosciences.
[15] P. Hjemdahl,et al. Co-release of neuropeptide Y and catecholamines during physical exercise in man. , 1985, Biochemical and biophysical research communications.
[16] B. Fredholm,et al. Perivascular peptides relax cerebral arteries concomitant with stimulation of cyclic adenosine monophosphate accumulation or release of an endothelium-derived relaxing factor in the cat , 1985, Neuroscience Letters.
[17] F. Sundler,et al. Calcitonin gene-related peptide is present in mammalian cerebrovascular nerve fibres and dilates pial and peripheral arteries , 1985, Neuroscience Letters.
[18] E. Högestätt,et al. Influence of extracellular calcium and nifedipine on α1‐and α2‐adrenoceptor‐mediated contractile responses in isolated rat and cat cerebral and mesenteric arteries , 1985 .
[19] R. Furchgott,et al. Selective blockade of endothelium-dependent and glyceryl trinitrate-induced relaxation by hemoglobin and by methylene blue in the rabbit aorta. , 1985, The Journal of pharmacology and experimental therapeutics.
[20] E. Högestätt,et al. On the mechanism of action of calcium antagonists. , 2009, Acta medica Scandinavica. Supplementum.
[21] J. Pernow,et al. Guanethidine-sensitive release of neuropeptide Y-like immunoreactivity in the cat spleen by sympathetic nerve stimulation , 1984, Neuroscience Letters.
[22] F. Schon,et al. PRESENCE OF NEUROPEPTIDE Y IN HUMAN CIRCLE OF WILLIS AND ITS POSSIBLE ROLE IN CEREBRAL VASOSPASM , 1984, The Lancet.
[23] B. Weir,et al. A randomized placebo-controlled double-blind trial of nimodipine after SAH in monkeys. Part 2: Pathological findings. , 1984, Journal of neurosurgery.
[24] P. Emson,et al. Neuropeptide Y: Cerebrovascular innervation an vasomotor effects in the cat , 1983, Neuroscience Letters.
[25] B. Hindfelt,et al. Prostaglandin metabolism and prostacyclin in cerebral vasospasm. , 1983, General pharmacology.
[26] L. Edvinsson,et al. Mechanical properties of rat cerebral arteries as studied by a sensitive device for recording of mechanical activity in isolated small blood vessels. , 1983, Acta physiologica Scandinavica.
[27] T. Hökfelt,et al. Neuropeptide Y (NPY)-like immunoreactivity in peripheral noradrenergic neurons and effects of NPY on sympathetic function. , 1982, Acta physiologica Scandinavica.
[28] J. Mcculloch,et al. Substance P: immunohistochemical localization and effect upon cat pial arteries in vitro and in situ. , 1981, The Journal of physiology.
[29] R. Furchgott,et al. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine , 1980, Nature.
[30] J. Church,et al. Calcium antagonistic drugs. Mechanism of action. , 1980, Canadian journal of physiology and pharmacology.
[31] S. Moncada,et al. Responses of human and baboon arteries to prostaglandin endoperoxides and biologically generated and synthetic prostacyclin: their relevance to cerebral arterial spasm in man. , 1979, British journal of clinical pharmacology.
[32] Smith Hs. Letter: Fortified flour. , 1975 .